Skip to main content

Table 1 Demographic and baseline features of the patients

From: Role of the mTOR pathway in minor salivary gland changes in Sjogren’s syndrome and systemic sclerosis

 

Sjogren’s syndrome (n = 58)

Systemic sclerosis (n = 14)

Overlap syndrome (n = 23)

Age, years (mean ± SD)

52.6 ± 13.1

53.9 ± 14.2

48.0 ± 9.3

Duration of disease, months (mean ± SD)

58.3 ± 23.4

43.0 ± 23.9

56.8 ± 35.4

Sicca symptom positivity, %

90

77

70

Schirmer test positivity, %

58

50

58

Breakup time test positivity, %

60

36

74

Anti-Ro (SSA) or La (SSB) positivity, %

96

55

71